# Secondary Prevention of Osteoporosis

> **NCT00421343** · PHASE3 · COMPLETED · sponsor: **Hebrew SeniorLife** · enrollment: 29 (actual)

## Conditions studied

- Osteoporosis

## Interventions

- **DRUG:** alendronate with cholecalciferol
- **DRUG:** calcium carbonate with cholecalciferol
- **BEHAVIORAL:** Falls prevention measures

## Key facts

- **NCT ID:** NCT00421343
- **Lead sponsor:** Hebrew SeniorLife
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 29 (ACTUAL)
- **Last updated:** 2020-02-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00421343

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00421343, "Secondary Prevention of Osteoporosis". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00421343. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*